The mission of CNICS is to provide access to the specimen and data repository to any investigator who submits an approved concept proposal. CNICS is a ‘peer-reviewed open access’ research platform available to investigators world-wide.

Upon submission of a concept study, the CNICS Administration will check for overlapping ideas or aims with an existing CNICS study to ensure each study has a unique data set without conflict. Should a new study be submitted that includes overlap, the CNICS Administration will work with researchers of both concepts to collaborate where research interests align.

CNICS has reviewed over 180 concept studies to date submitted by investigators at all levels, including graduate students, fellows, staff and faculty. These studies have resulted in over 350 peer reviewed manuscripts and over $125M in external funding awards to investigators working in CNICS, the majority of which are early career faculty and trainees.

Concept NumberTitle of Concept StudyInvestigator(s) NameInstitute
001Impact of HAART and Metabolic Complications on Myocardial Infarction and Survival among HIV-infected PatientsHeidi CraneUniversity of Washington (UW)
002 Incidence and Risk Factors for Triple Class Antiretroviral Regimen (ARV) Exposure and Failure in the CNICS CohortRichard HaubrichUniversity of California San Diego (UCSD)
003Biological and behavioral correlates of ART adherence and depression across diverse patients in the CNICS cohortsSteven SafrenFenway
004 The incidence and correlates of HIV superinfection before starting and after stopping antiretroviral therapyDavey SmithUniversity of California San Diego (UCSD)
005Viral Variation and the Development of Neutralizing AntibodiesNancy L. HaigwoodUniversity of Washington (UW)
006 gd-T cell Impairment and AIDS-associated CancersRichard LopezUniversity of Alabama at Birmingham (UAB)
007STI Burden and Behavioral Risks among HIV-infected Patients in Primary Care at CNICS collaborating sitesKenneth MayerFenway
008 Genetic variation and drug-drug interactions in tenofovir induced nephrotoxicity Kathleen GiancominiUniversity of California San Francisco (UCSF)
009 Predictors of Severe Liver Enzyme Elevation and Immunologic Response to Initial HAART in Patients with HIV and Hepatitis Co-InfectionChad AchenbachNorthwestern
010 Eligibility for Early Initiation of Highly Active Antiretroviral Therapy (HAART) to Decrease HIV Transmission/ Julie Dombrowski UWJulie DombrowskiUniversity of Washington (UW)
011 Durability and Effectiveness of First-line ARV Regimens in treatment-naïve Patients Initiating Therapy in a Clinical Practice SettingMichael MugaveroUniversity of Alabama at Birmingham (UAB)
012 Association of cellular immune function and phenotype with severe liver enzyme elevation (LEE) after Highly Active Antiretroviral Therapy (HAART) among HIV and viral hepatitis co-infected patientsChad AchenbachNorthwestern
013 Long-term virologic outcomes of HIV-infected patients coinfected with hepatitis B on tenofovir-containing HAARTNina Kim University of Washington (UW)
014 Prevalence and associations of unprotected sex and substance use in the CNICS cohortMatthew MimiagaFenway
015 Dynamic Assessment of Virologic Response and Mortality Among HIV-infected Patients Initiating Antiretroviral TherapyMichael MugaveroUniversity of Alabama at Birmingham (UAB)
016 An Analysis of Renal Function Before and After the Initiation of Highly Antiretroviral Therapy (HAART) to Examine Correlates of Renal Function Preservation and DeclineRobert KalayjianCase Western Reserve University (CWRU)
017 HIV Pathogenesis and Immunity in Viremic Non-ProgressorsDavid CameriniUniversity of California Irvine (UC Irvine)
018 The Predictors of HIV+ smokers and investigation of smoking recognition and intervention by providers in two HIV ambulatory clinicsKaren CropseyUniversity of Alabama at Birmingham (UAB)
019 Molecular Epidemiology of HIV Transmission and Transmitted Resistance in Women and Minorities in the CNICS CohortJeannette AldousUniversity of California San Diego (UCSD)
020HIV infection in Sickle Cell DiseaseMichael LedermanCase Western Reserve University (CWRU)
021 Generalizing evidence from randomized clinical trials to target populations: the ACTG-320 trialSteve ColeUniversity of North Carolina at Chapel Hill (UNC)
022 Comparison of plasma HIV RNA with CD4+ T cell count-based strategies for detection of first line treatment failure and initiation of regimen modificationMaya PetersonUniversity of California Berkeley
023 Measuring HIV transmission risk among HIV+ patients at CNICS sitesJoseph SchumacherUniversity of Alabama at Birmingham (UAB)
024AIDS-defining and non-AIDS defining malignancies among the CFAR Network of Integrated Clinical Systems (CNICS) Michael SaagUniversity of Alabama at Birmingham (UAB)
025 Effects of Hepatitis B co-infection on HIV Antiretroviral Therapy Response and Long-term OutcomesSarah RadkeUniversity of North Carolina at Chapel Hill (UNC)
026 Heterogeneity in Cytokine Responses to HIV-1 InfectionJames TangUniversity of Alabama at Birmingham (UAB)
027 Methods to migrate from the 9-item Patient Health Questionnaire (PHQ-9) to computerized adaptive administration of the Patient Reported Outcomes Measurement Information System (PROMIS) depression measurHeidi CraneUniversity of Washington (UW)
028 HIV Infection and Response to Initial Therapy for Type 2 DiabetesUniversity of Pennsylvania (UPENN)
029Contribution of enzyme (protease) and substrate (gag) mutations to protease inhibitor resistanceDavid LooneyUniversity of California San Diego (UCSD)
030Epidemiology & Outcomes of HIV-2 in the United StatesGeoffrey GottliebUniversity of Washington (UW)
031Adherence to Clinical Care and Survival among HIV-infected Patients Initiating Antiretroviral TherapyMichael MugaveroUniversity of Alabama at Birmingham (UAB)
032HIV in the Elderly: Evaluating Indoleamine 2,3 dioxygenase as a marker for disease statusStephanie BaerMedical College of Georgia
033HIV-associated Obstructive Pulmonary Disease Examinations (HOPE): Risk, Exacerbations, and OutcomesKristina CrothersUniversity of Washington (UW)
034Prognosis of incidence and progression risk of AIDS-defining and non-AIDS-defining malignancies in HIV/AIDS patientsJulia KrauchankaDuke University
035Body morphology abnormalities and patient reported outcomes: depression, adherence, health-related quality of life, substance use, physical activity, and sexual risk behaviorHeidi CraneUniversity of Washington (UW)
036Routine Laboratory Monitoring During Virologically Suppressive Combination Antiretroviral Therapy in the USBabafemi TaiwoNorthwestern
037Fine mapping of MHC susceptibility loci for AIDS-related non-Hodgkin lymphomaBrahim AissaniUniversity of Alabama at Birmingham (UAB)
038The Timing of Antiretroviral Initiation among ART Naïve HIV Infected patients in routine clinical practiceElvin GengUniversity of California San Francisco (UCSF)
039Cross-walk between commonly used measures of anxiety in patients with HIV and the Patient Reported Outcomes Measurement Information System (PROMIS) anxiety measureHeidi CraneUniversity of Washington (UW)
040Determinants of Transmitted Drug Resistance (TDR) and Impact of “Test and Treat” Strategy on Transmission of Drug Resistance Among HIV-1 Infected Treatment-Naïve Patients: Influence of High Risk Behaviors as Determined by Patient Based Metrics (PBM) on TDR Prevalence and Modeled Probability of TransmissionVi BowmanUniversity of California San Diego
041Systematic Characterization of High-Risk HPV Infection in Head and Neck Carcinoma in HIV+ IndividualsMargaret Brandwein-GenslerUniversity of Alabama at Birmingham
042Durability of initial compared to subsequent HAART regimensEric SahloffUniversity of Toledo
043Comparing Results from Two Methods for Estimating the Optimal CD4 Threshold for Initiating Antiretroviral TherapyBryan ShephardVanderbilt University
044Biological Determinants of Long-term Immune Reconstitution following Combination Antiretroviral Therapy (cART)Sharon LewinMonash University Australia
045BMI, Depression, and HIV Self-Care Behaviors among MSMAaron BlashillFenway
046Impact of presenting clinical features and subsequent treatment on outcomes after non-CNS HIV-associated lymphoma in the CNICS cohortSatish GopalUniversity of North Carolina at Chapel Hill (UNC)
047Time related factors of platelet count reduction in human immunodeficiency virus/HIV and Hepatitis C/HCV co-infected antiretroviral therapy/ARV Naiive patientsChris DelaneyUniversity of Florida
048Structural models for exposure effects in HIV progression cohortsSteve ColeUniversity of North Carolina at Chapel Hill (UNC)
049Effects of Combination Antiretroviral Therapy on Risk of Non-AIDS- defining Cancers/ STUDY CLOSEDElizabeth YanikUniversity of North Carolina at Chapel Hill (UNC)
050The Causal Effect of Antidepressant Treatment on HIV Outcomes in the CNICS Multi-Site Observational Clinical Cohort: An Application of Marginal Structural ModelsBrian PenceDuke University
051Risk Factors and microRNA Profiles of HIV Associated Lung CancerKristina Crothers and Lynn SchnappUniversity of Washington (UW)
052Molecular epidemiology of HIV transmission networks between Rhode Island and MassachusettsPhillip ChanBrown University
053Incidence and treatment of prostate cancer in HIV-infected men: do racial disparities exist?Ramona BhatiaNorthwestern
054Impact of Transitioning from HIV Clinical Trials to Routine Medical Care on Virologic and Immunologic OutcomesBaligh R. YehiaUniversity of Pennsylvania (UPENN)
055Current practice of screening for incident HCV infection among HIV-infected individualsBenjamin LinasBoston Medical Center
056Evaluating the Relationship between HIV Transmission Networks in the San Diego-Tijuana Cross-Border HIV Epidemic and the Rest of the United States and the Difference between Geographically Localized and Geographically Diverse Transmission NetworksSanjay MehtaUniversity of California San Diego (UCSD)
057The Natural History of Malignancies Developing Among HIV Positive Individuals on Stable Antiretroviral TherapyAnna CoghillUniversity of Washington (UW)
058Endothelial Dysfunction, Antiretroviral Therapy, and Non-AIDS Defining Events in the CNICS CohortSusan GrahamUniversity of Washington (UW)
059When to switch cART: A comparison of switching strategies using observational dataLauren CainHarvard University
060Effects of Hepatitis C Co-infection on HIV Disease Progression and Long term OutcomesJennifer LingUniversity of Washington (UW)
061Frailty in HIV-infected older adultsCharles Kamen and Supriya MohileUniversity of Rochester
062STI Screening and Determinants of Infection Among HIV-Infected Patients in Primary CareKenneth MayerFenway
063Diagnosis and Treatment of Depression in HIV/AIDS Primary Care: A Comparative Analysis of Latino and Non-Latino White PatientsOscar BeltranUniversity of Texas at El Paso (UTEP)
064Behavioral predictors of outcomes in HIV infected adolescents
Brian ZanoniMassachusetts General Hospital, Fenway Community Health
065Optimal timing for starting cART in antiretroviral-naïve HIV-1–infected patients presenting with cryptococcal meningitisJonathan SterneUniversity of Bristol
066Plasma cell neoplasms in HIV infected people: a multi center case series/ STUDY CLOSED

Eric EngelsNational Cancer Institute
067Molecular profiling of HIV-associated lymphoma occurring before and during antiretroviral therapySatish GopalUniversity of North Carolina at Chapel Hill (UNC)
068Alcohol Research Consortium in HIV – Epidemiological Research Arm (ARCH-ERA)
U01AA020793
Heidi CraneUniversity of Washington (UW)
068bAlcohol Research Consortium in HIV: COVID SupplementHeidi CraneUniversity of Washington (UW)
069Comparative effectiveness of SSRIs and SGAs among patients aging with HIVHeidi CraneUniversity of Washington (UW)
070OMCICH: Optimal Multidisciplinary Care in the Clinical HIV SettingMichael HorbergMid-Atlantic Kaiser Permanente Group
071Factors that influence the response to Hepatitis A vaccine among HIV-infected individualsHeidi CraneUniversity of Washington (UW)
072Statins in HIV: Immune Reconstitution, Comorbid Events, and SurvivalDan DrozdUniversity of Washington (UW)
073Epidemiology of Cerebrovascular Disease in CNICSDavid TirschwellUniversity of Washington (UW)
074Race-specific association between CCR5 -2459G>A genotype and virologic response to HAART in the CNICS cohort/ STUDY CLOSEDRajeev MehlotraCase Western Reserve University (CWRU)
075Modeling the dynamic association of BMI and mortality in HIV positive adults/ STUDY CLOSEDJianghua HeUniversity of Massachusetts (UMASS)
076Relationship of virologic suppression and control of cardiometabolic comorbidities in HIV-infected patients on antiretroviral therapyGreer BurkholderUniversity of Alabama at Birmingham (UAB)
077Incidence and treatment of anal cancer in HIV-infected individuals: do racial/ethnic disparities exist?Candice McNeil Stanford University
078Hepatitis C treatment uptake and predictors of HCV therapy among HIV-infected individuals in the era of direct-acting antiviral agents

Ed CachayUniversity of California San Diego (UCSD)
079Sero-incidence of Herpes Simplex Virus Types 1 and 2 in HIV-infected persons receiving HIV-care Nicholas Van WagonerUniversity of Alabama at Birmingham (UAB)
080Circulating MicroRNAs in HIV-infected Patients with and without Coronary Artery DiseaseVenkata Narla and Priscilla HsueUniversity of California San Francisco
081Understanding Patient Populations Receiving Antiretroviral Therapy: Observational Channeling Bias StudyMichael Saag, Steve Cole and Andy WestfallUniversity of Alabama at Birmingham (UAB) & University of North Carolina at Chapel Hill (UNC)
082Assessment of Markers of Microbial Translocation, Gut Mucosal Integrity, and Inflammation in HIV-infected Patients with Delayed Vs. Normal Immune Recovery on Suppressive Antiretroviral TherapyGregory Huhn, Peter Hunt and Bellur PrabhakarChicago Cook County Hospital
083Effectiveness of Antiretroviral Therapy (ART) with Upfront Chemotherapy versus ART Alone in HIV-Infected Patients with Kaposi’s Sarcoma Who Do Not Have Urgent Indications for Chemotherapy/ STUDY CLOSED
Jackie WangUniversity of California San Francisco (UCSF)
084Selection bias due to restriction in cohort studiesChanelle HoweBrown University
085Antiretroviral switches in HIV/HCV co-infected patients: Initiating direct acting antiviral therapies for Hepatitis C Infection

Julius Wilder and Susanna NaggieDuke University
086HIV-related Health Disparities in Latinos Living with HIV in the United StatesJohn SaucedaUniversity of California San Francisco
087When to monitor: A comparison of immunologic and virologic monitoring strategies using observational dataEllen CanigliaHarvard University
088Differential Virologic and Resistance Outcomes when using
Efavirenz-based Single Tablet Regimens versus Multiple Tablet
Regimens in HIV Treatment
Michael Saag and Andy WestfallUniversity of Alabama at Birmingham (UAB)
089Calcium antagonist and CVD risk among hypertensive HIV+ patientsSadeep ShresthaUniversity of Alabama at Birmingham (UAB)
090Identify and Manage Promptly Incident Hepatitis C: Testing to Treatment in HIV (IMPACT-C)/ STUDY CLOSED

Benjamin Linas and Lynn TaylorBoston Medical Center
091Preventive fractions of Kaposi sarcoma and non-Hodgkin lymphoma in the modern ART eraElizabeth YanikNational Cancer Instittute
092Application of the Updated ACC/AHA Atherosclerotic CVD Risk Assessment Tool and Prevention Guidelines Among HIV-Infected Individuals: CFAR Network of Integrated Clinical Systems (CNICS)Matthew FeinsteinNorthwestern
093Analysis of CNICS data to inform design of interventions to enhance HIV care among substance abusersBryan HartzlerUniversity of Washington (UW)
094Population interventions on smoking in the CNICS/ Bryan Hartzler UWBryan HartzlerUniversity of Washington (UW)
095Factors Associated with HAART Medication Adherence among Older Adults Living with HIV in the U.S.Brian WittUniversity of North Carolina at Chapel Hill (UNC)
096The Affordable Care Act, Socioeconomic Context, Spatial Mapping, and Outcomes Among People Living With HIVAadaora AdimoraUniversity of North Carolina at Chapel Hill (UNC)
097Pathways contributing to racial and economic disparities among HIV clinic cohort patients/ STUDY CLOSEDChanelle BrownBrown University
098Genomic approaches to cardiometabolic risk and treatment in HIVInga PeterMount Sinai
099Investigating the relationship between chronic pain and HIV outcomesJessie MerlinUniversity of Alabama at Birmingham (UAB)
100Cardiovascular, pulmonary, and hematological disease in HIV: Prevention and TreatmentHeidi CraneUniversity of Washington (UW)
101Statin use among HIV-infected patientsGreer BurkholderUniversity of Alabama at Birmingham (UAB)
102Comparative Effectiveness of Single-Action verses Multi-Action Antidepressants on Depression, Treatment Adherence and HIV Clinical Outcomes among People Living with HIV/AIDS and DepressionJon MillsUniversity of North Carolina at Chapel Hill (UNC)
103Development and Validation of a Multidimensional Index of Engagement in HIV Care Kristian Christopoulos and Mallory JohnsonUniversity of California San Francisco (UCSF)
104Calibration of a 1-Year Virologic Prediction Rule for Race/Ethnicity and Gender.Gregory RobbinsMass Gen/ Harvard University
105The HIV Care Continuum: CD4 and Viral Load Measures as Proxies for Routine HIV Care Visits  Kimberly PowersUniversity of North Carolina at Chapel Hill (UNC)
106Diminishing “Clinic Viral Load” in CNICS clinics in the U.S.: Socio-demographic and Therapeutic Correlations with Adherence  Jane SimoniUniversity of Washington (UW)
107The CD4/CD8 ratio as a predictor of adverse outcomes in HIV-infected subjects under suppressive antiretroviral therapy and elite controllersSergio Serrano-VillarUniversity Hospital Ramón y Cajal- Madrid, Spain
108Modeling Depression Treatment Strategies for Human Immunodeficiency Virus (HIV) Positive PatientsRongbing XieUniversity of Alabama at Birmingham (UAB)
109Physical activity patterns and metabolic disease outcomes in people living with HIV  Amanda WilligUniversity of Alabama at Birmingham (UAB)
110Projected Burden of Chronic Disease within the PLWH Population Julia HoodUniversity of Washington (UW)
111Impact of low-level HIV viremia on cancer riskJennifer LeeUniversity of North Carolina at Chapel Hill (UNC)
112A statistical framework for integrated analysis of the HIV care cascade using CNICS dataHanna LeeBrown University
113What to start: co-formulated versus individual tablets regimens in high-income countriesSarah LodiHarvard University
114Self-management and quality of life in persons with HIV and diabetes, a comparison study.Julie ZunigaUniversity of Texas Austin
115Lipidomic Profiling in HIV patients newly initiating antiretroviral treatmentRyan IrvinUniversity of Alabama at Birmingham (UAB)
116Identification of Novel Metabolic Biomarkers for Predicting Cardiovascular Events in Persons Living with HIVSvati ShahDuke University
117Supplement to Approved CP 103: Development and Validation of a Multidimensional Index of Engagement in HIV CareKristina Christopoulos and Mallory JohnsonUniversity of California San Francisco (UCSF)
118Efavirenz and the risk of suicidalityAngela BengstonUniversity of North Carolina at Chapel Hill (UNC)
119Age and Risk of HAART-Associated Nephrotoxicity: a Retrospective Cohort StudyJessie TorgersenHospital of the University of Pennsylvania
120Pathways contributing to racial/ethnic disparities among HIV clinic cohort patientsChanelle HoweBrown University
121Combined when to start analyses of the START trial, HIV-CAUSAL and CNICSSteve ColeUniversity of North Carolina at Chapel Hill (UNC)
122At-Risk Alcohol Use and the Completion of Patient Reported OutcomesJacquelin RudolphUniversity of North Carolina at Chapel Hill (UNC)
123Examining causes of death among patients with HIV in the United States: methodologic tools and applicationsJess EdwardsUniversity of North Carolina at Chapel Hill (UNC)
124Health Outcomes Among Transgender Patients in HIV Care: Findings from the CNICS CohortSari ReisnerFenway
125Durability of Contemporary Antiretroviral Regimens in Treatment Naïve Persons living with HIVEllen EatonUniversity of Alabama at Birmingham (UAB)
126Phylogeographic approach to determine the dynamics of HIV in circulating cellular reservoirs during ART failure and after re-suppression.Antoine ChaillonUniversity of California San Diego (UCSD)
127Kidney Failure Risk Projection for the HIV-infected Living Kidney Donor CandidateJayme LockeUniversity of Alabama at Birmingham (UAB)
128The Syndemics of Aging with HIVMaile KarrisUniversity of California San Diego (UCSD)
129Hemoglobin as a criterion to switch antiretroviral therapy in HIV-positive individualsLauren CainHarvard University
130Comparative effectiveness of integrase-inhibitor-based regimens versus NNTRI- and boosted-PI-based regimens.Steve ColeUniversity of North Carolina at Chapel Hill (UNC)
131Patient-reported sexual risk behavior and viral suppression over timeJulia RaifmanJohn Hopkins Bloomberg School of Public Health
132Comparing Duraility, Treatment Failure and Emergence of Resistance on Integrase Stand Transfer Inhibitor Treatment Regimens Among Treatment-Naïve and Treatment-Experienced Patients with HIV (UAB Protocol # X151228001)Heidi CraneUniversity of Washington (UW)
133A Feasibility and Pilot Study of Clinical Outcomes among Transgender Women Living with HIV Tonia PoteatJohn Hopkins Bloomberg School of Public Health
134The impact of substance use on health outcomes over time among persons living with HIV W. Scott ComuladaUniversity of California Los Angeles (UCLA)
135The Joint Effects and Plausible Interventions for ART and Statin Use on MortalityJonathan PostUniversity of North Carolina at Chapel Hill (UNC)
136Multi-level Social and Behavioral Determinants of Health and Missed HIV Healthcare Provider VisitsApril PettitVanderbilt University
137Physical Activity and Symptom Distress in HIV+ Adults in the CNICS DatabaseAllison WebelCase Western Reserve University
138Statin use to prevent progression of liver disease among HIV infected individualsBryan LauJohn Hopkins University
139Real World Effectiveness of Direct-Acting Antiviral Agents for Hepatitis C Infection Among HIV/HCV-Coinfected PatientsNina KimUniversity of Washington (UW)
140Cigarette Smoking and HIV Treatment Outcomes Among MSM in Primary CareConall O'CleirighHarvard University
141Epidemiology of Heavily Treatment-Experienced (HTE) HIV Patients in the USMichael Saag and Ellen EatonUniversity of Alabama at Birmingham (UAB)
142Development and Validation of Risk Prediction Model for End Stage Liver Disease and Hepatocellular Carcinoma in Persons living with HIVNina KimUniversity of Washington (UW)
143Evaluation of the efficacy, mechanism, and cost-effectiveness of Skills TO Manage Pain (STOMP), a novel group and peer-based behavioral intervention for chronic pain tailored to people living with HIVJessie MerlinUniversity of Alabama at Birmingham (UAB)
144Rates and Predictors of Bacterial STI in Women with HIVJodie Dionne-OdomUniversity of Alabama at Birmingham (UAB)
145Diabetes as a risk factor for tuberculosis in HIV positive individuals in the United StatesKristina BajemaUniversity of Washington (UW)
146A personalized approach to mental health in HIVTodd FojoJohn Hopkins University
147Epidemiology of HIV-related atrial fibrillation and associations with substance abuseSusan HeckbertUniversity of Washington (UW)
148Estimating the potential pool of HIV-infected deceased organ donors in the United StatesJayme LockeUniversity of Alabama at Birmingham (UAB)
149Primary Infection Resource Consortium (PIRC)Susan LittleUniversity of California San Diego (UCSD)
150Patterns and Perceptions of e-Cigarettes and Vaporized Nicotine Among People Living with HIV Rob FredericksenUniversity of Washington (UW)
151Longitudinal HIV Care Trajectories and HIV Transmission Risk from the Time of HIV Care Entry in the CNICSKimberly PowersUniversity of North Carolina at Chapel Hill (UNC)
152Condom-less sex behavior and health outcomes among HIV-infected patients in the PrEP eraRob FredericksenUniversity of Washington (UW)
153Patient Usability and Acceptability of Electronic Patient-Reported Outcome Measures for Use in HIV CareRob FredericksenUniversity of Washington (UW)
154Plasma IL-6 signaling biomarkers and cardiovascular disease in the CNICS cohortLee SulggiUniversity of California San Francisco (UCSF)
155HIV/HCV Coinfection and Incidence of Extrahepatic CancersJulia MarcusHarvard University
156Predictive Analytics for Retention in HIV CareJessica RidgwayUniversity of Chicago
157Understanding the effect of physical activity and dietary intake on the longitudinal symptom experience of HIV+ adults in the CNICS cohortAllison Webel and Amanda WilligCase Western Reserve University (CWRU) & University of Alabama at Birmingham (UAB)
157aExamining HIV-related Symptom Moderation of the Executive Function/Self-Management ProcessNathaniel SchreinerCase Western Reserve University (CWRU)
158Preparing for Long-Acting Injectable ART: Patient and Provider Perceptions, Preferences, and Shared Decision-Making David WohlUniversity of North Carolina at Chapel Hill (UNC)
159Health Outcomes among Patients in HIV Care Reporting Intimate Partner ViolenceRob FredericksenUniversity of Washington (UW)
160
Impact and Correlates of Sub-Optimal Social Support Among Patients in HIV CareRob FredericksenUniversity of Washington (UW)
161Health Disparities and Social Determinants for HIV-Associated Neurocognitive Disorders and its Risk Factors Pariya Fazeli Wheeler University of Alabama at Birmingham (UAB)
162Viral suppression and sexual risk among people living with HIV: potential impact of risk compensation on HIV transmission Heather PinesUniversity of California San Diego (UCSD)
163Improving Kidney Health for African Americans with HIV through Optimal Antiretroviral Therapy SelectionEllen Eaton University of Alabama at Birmingham (UAB)
164Role of medication assisted treatment on HIV treatment outcomes among opioid and stimulant usersJavier CepedaUniversity of California San Diego (UCSD)
165Effectiveness of second-line antiretroviral therapyThibaut Davy-MendeUniversity of North Carolina at Chapel Hill (UNC)
166Genes, substance use, and HIV outcomes in people living with HIV across the USHeidi CraneUniversity of Washington (UW)
167Interventions to prevent cardiovascular disease among people living with HIVAlexander BreskinUniversity of North Carolina at Chapel Hill (UNC)
168Characterization of Symptom Clusters Among People Living With HIV DiseaseNatalie WilsonUniversity of California San Francisco (UCSF)
169Effectiveness of a smoking cessation algorithm integrated into HIV primary care.Karen Cropsey University of Alabama at Birmingham (UAB)
170Determinants and Outcomes of Nicotine Metabolism in HIVRobert GrossUniversity of Pennsylvania (UPENN)
171Marijuana policy change impact on patterns of marijuana and other harmful substance use among people living with HIV: a mixed methods evaluationAndrew HahnUniversity of Washington (UW)
172Prevalence and Risk Factors for Hepatitis Delta Infection Among a Cohort of HIV/Hepatitis B-Coinfected Patients in the United StatesVincent Lo ReUniversity of Pennsylvania (UPENN)
173Optimizing the Implementation of the U=U Strategy for HIV Prevention in Clinic SettingsCurt BeckwithBrown University
174Substance use and risk of stroke among people living with HIVThomas MartinUniversity of California San Diego (UCSD)
175Host genetics and risk of anal cancer among patients living with HIVHelen Stankiewicz KaritUniversity of Washington (UW)
176Genetic predictors of adiposity-related traits including body mass index, lipoatrophy, lipohypertrophy and ART treatment-induced obesity among people living with HIVSara LindstroemUniversity of Washington (UW)
177Gender Identity and Participation in Biomedical ResearchApril PettitVanderbilt University
178Differences in substance use patterns among people living with HIV by geographic regionHeidi CraneUniversity of Washington (UW)
179Mental health, alcohol, and other substance use disorders Prevalence, co-occurrence and durability of symptoms; pharmacologic treatment initiation and retention; and impact of treatment on retention in HIV care and viral suppressionCatherine LeskoJohn Hopkins University
180Factors associated with Initiating Care for Vulnerable HIV-Infected Individuals with Substance Use Canada ParrishUniversity of Washington (UW)
181Title of Concept: Evaluating the impact of food insecurity on diabetes risk and treatment outcomes among adults with HIV+ in the PROSPER-HIV studyAllison Webel and Amanda WilligCase Western Reserve University (CWRU) & University of Alabama at Birmingham (UAB)
182Machine learning to identify persons at high-risk of disengaging from HIV care in the United StatesSahar SaeedWashington University in St. Louis
183Impact of COVID-19 among people living with HIV in the CNICS cohort: overall and symptomatic incidence, predictors of disease, adverse clinical outcomes, and mortality Ed Cachay, Lalo and Adrienne ShapiroUniversity of Washington (UW)
184Impact of FUT2 Genetic Variability on HIV-associated Inflammation.Mohamed Abdel-MohsenWistar Institute
185Quality of life validation studies in CNICSHeidi CraneUniversity of Washington (UW)
186Impact of childhood abuse on health outcomes among patients living with HIVRob FredericksenUniversity of Washington (UW)
187Burden of Morbidity and Premature Mortality in patients with HIV-associated Malignancies
Guarav GoyalUniversity of Alabama at Birmingham (UAB)
188Antiretroviral Utilization in the Current Treatment Era (2018-2020)Jimmy MaUniversity of Washington (UW)
189Patient Perceptions of the Impact of the SARS-CoV-2 pandemic: Impact on patient reported outcomes and HIV-related outcome disparitiesMallory JohnsonUniversity of California San Francisco (UCSF)
190Trauma and adherence: A lifecourse approach to understanding HIV in older adultsPaul NashUniversity of Southern California
191A cross sectional analysis of psychological stress, physical activity, and viral suppression as predictors of Cardiovascular Disease risk in older persons with HIVCrista IrwinEmory University
192Mentoring Patient-Oriented Research on Advances to Optimize Engagement in HIV Care Katerina ChristopoulosUniversity of California San Francisco (UCSF)
193Relationship between body fat and functional status among adults aging with HIVVitor OliveiraCase Western Reserve University
194Deep Phenotyping of HIV-Related Heart FailureMatthew FeinsteinNorthwestern
195Internalized HIV Stigma and Viral Suppression: Examining the Mediating and Moderating Roles of Social Support, Substance Use, and Depressive SymptomsTimothy CrawfordWright State University Boonshoft School of Medicine
196Psychosocial Effects of HIV Nondisclosure Laws Among People Living with HIVSteve SafrenUniversity of Miami
197Changes in weight after switching off of integrase strand transfer based regimens does the next regimen matterJeff YinUniversity of California San Diago (UCSD)
198Determination of the Impact of Abnormal Glucose Levels on Progression to Frailty Among People Living with HIVAndrew HahnUniversity of Washington (UW)
199Social Determinants of Health Disparities and Multiple Co-morbidities among Men and Women Living with HIVJenni WiseUniversity of Alabama at Birmingham (UAB)
200Examining influences on physical activity behaviors and quality of life among adults living with HIVSable WatsonUniversity of North Carolina at Chapel Hill (UNC)